Julphar Bangladesh Ltd. Julphar Bangladesh Ltd.

Julphar Bangladesh has introduced Roxibac Plus (Cefuroxime + Clavulanic acid)


Julphar Bangladesh is passionate to introduce new and better molecules, strengths & dosage forms of various therapies in the market. Another feather of this effort is Roxibac Plus (Cefuroxime & Clavulanic acid) the most trusted antibiotic combination as Roxibac Plus 250 & Roxibac Plus 500 tablet.

Cefuroxime, a broad spectrum second generation Cephalosporin has excellent efficacy against a wide range of common pathogens. The main reason of cefuroxime resistance is the production of β-lactamase enzyme by pathogens. Clavulanic acid has a β-lactam like structure which can bind irreversibly to the β-lactamase enzymes. It plays the key role to protect cefuroxime from degradation by β-lactamase enzymes. Thus this combination ideally overcomes the resistances.

• Highly effective against β -lactamase producing bacteria
• Highly effective in gynaecological & respiratory tract infection
• Both cefuroxime and clavulanic acid are US FDA pregnancy Category B
• API from certified sources ( US FDA, MHRA, EDQM)
• Ensures five layers protection

Last Update: 23 Jan 2018

© Julphar Bangladesh Ltd. 2008 - 2018. All Rig hts Reserved.
Developed By : Alien BD Inforamtion & Technology